Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction.
Asami Sukeishi; Kotaro Itohara; Atsushi Yonezawa; Yuki Sato; Katsuyuki Matsumura; Yoshiki Katada; Takayuki Nakagawa; Satoshi Hamada; Naoya Tanabe; Eishi Imoto; Shinichi Kai; Toyohiro Hirai; Motoko Yanagita; Shigeru Ohtsuru; Tomohiro Terada; Isao Ito
CPT: pharmacometrics & systems pharmacology, 2021年11月18日, 査読有り